TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25112087

Group type: EXPERIMENTAL
Intervention: Spreading moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium tablets (caltrate, 600 mg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium tablets
Number of subjects: 60
Study: 21838764

Group type: EXPERIMENTAL
Intervention: Web-based pedometer programme
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (letter about diabetes risk reduction)
Number of subjects: 49
Study: 19657398

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg daily
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 921
Study: 17226908

Group type: EXPERIMENTAL
Intervention: Continuous ciprofloxacin treatment (200 mg intravenous injection for 30 min before ERCP and continued until 48 hours after ERCP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Discontinuous ciprofloxacin treatment (200 mg intravenous injection for 30 min before ERCP and discontinued after ERCP)
Number of subjects: 48
Study: 15891132

Group type: EXPERIMENTAL
Intervention: Chloroquine plus sulfadoxine‐pyrimethamine
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine‐pyrimethamine
Number of subjects: 1105
Study: 12086757

Group type: COMPARATOR
Intervention: Placebo (n=63)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: rFGF-2 (30 microg/kg) on day 1 and placebo on day 30 (single-dose, n=66)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: rFGF-2 (30 microg/kg) on days 1 and 30 (double-dose, n=61)
Number of subjects: 190
Study: 9869229

Group type: EXPERIMENTAL
Intervention: Whole pelvic irradiation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Prostate-only treatment
Number of subjects: 201
Study: 8594524

Group type: EXPERIMENTAL
Intervention: Bausch & Lomb ReNu (multipurpose contact lens care solution)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Bausch & Lomb Sensitive Eyes (physiological saline)
Number of subjects: 73
Study: 2470081

Group type: EXPERIMENTAL
Intervention: Fibrin glue pleurodesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tetracycline pleurodesis
Number of subjects: 0
Study: 937643

Group type: EXPERIMENTAL
Intervention: Operative cholangiography and extraductal palpation
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Routine extraductal palpation and selective cholangiography
Number of subjects: 1000
Study: 31337697

Group type: EXPERIMENTAL
Intervention: Lavage group (n = 20) - Continuous lavage by an automated PD machine from day 3 to 5 or 6
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20) - Usual PD schedule maintained
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20) - Stratified by CRP tertiles
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lavage group (n = 20) - Stratified by CRP tertiles
Number of subjects: 40
Study: 28870486

Group type: EXPERIMENTAL
Intervention: VitVOO (vitaminized olive oil)
Number of subjects: 60

Group type: COMPARATOR
Intervention: PlaVOO (placebo)
Number of subjects: 60
Study: 25381051

Group type: EXPERIMENTAL
Intervention: Ibrutinib (dose levels of 1.25-12.5 mg/kg/day and fixed dose of 560 mg/day)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Ibrutinib (fixed dose level of 560 mg/day)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Ibrutinib (fixed dose levels of 420 and 840 mg/day)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 245
Study: 23476053

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided (EG) transvenous LV lead placement
Number of subjects: 187

Group type: COMPARATOR
Intervention: Routine fluoroscopic approach (Control)
Number of subjects: 187
Study: 21676221

Group type: EXPERIMENTAL
Intervention: Lisinopril 5‐10 mg daily for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 60
Study: 19366273

Group type: EXPERIMENTAL
Intervention: Oral administration of 25 mg ketamine lozenge
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sublingual administration of 25 mg ketamine lozenge
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Norketamine/ketamine area under the plasma concentration-time curve
Number of subjects: 6
Study: 16427197

Group type: EXPERIMENTAL
Intervention: High plasma morphine concentrations (173+/‐11 ng/ml)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Saline days with rising methadone concentrations
Number of subjects: 28
Study: 15242427

Group type: EXPERIMENTAL
Intervention: Cold alpha-stat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold pH-stat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warm alpha-stat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warm pH-stat
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold groups (alpha-stat and pH-stat combined)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Warm groups (alpha-stat and pH-stat combined)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 16118380

Group type: EXPERIMENTAL
Intervention: Anesthesia-assisted rapid opioid detoxification with naltrexone induction
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Buprenorphine-assisted rapid opioid detoxification with naltrexone induction
Number of subjects: 106

Group type: COMPARATOR
Intervention: Clonidine-assisted opioid detoxification with delayed naltrexone induction
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Anesthesia-assisted detoxification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Buprenorphine-assisted detoxification
Number of subjects: 106

Group type: COMPARATOR
Intervention: Clonidine-assisted detoxification
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Naltrexone induction (50 mg)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Anesthesia procedure
Number of subjects: 106
Study: 10332529

Group type: EXPERIMENTAL
Intervention: Computer-based program for identifying drug-related problems
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Computer-based program
Number of subjects: 246
Study: 7990904

Group type: EXPERIMENTAL
Intervention: Zofenopril (772 patients)
Number of subjects: 1556

Group type: COMPARATOR
Intervention: Placebo (784 patients)
Number of subjects: 1556
Study: 2253982

Group type: EXPERIMENTAL
Intervention: EMLA Cream applied 1 hour prior to venous cannulation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo cream applied 1 hour prior to venous cannulation
Number of subjects: 75
Study: 7418714

Group type: EXPERIMENTAL
Intervention: 25 mg methotrexate bolus intravenous injection
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 100 mg methotrexate bolus intravenous injection
Number of subjects: 6
Study: 31674250

Group type: EXPERIMENTAL
Intervention: Distal femoral replacement (DFR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Internal fracture fixation
Number of subjects: 36
Study: 27067259

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham TES (Control)
Number of subjects: 28
Study: 27123806

Group type: EXPERIMENTAL
Intervention: Social worker contact
Number of subjects: 267

Group type: COMPARATOR
Intervention: Other incentive strategies
Number of subjects: 267
Study: 24512733

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C 320 mg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C 480 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 22489991

Group type: EXPERIMENTAL
Intervention: Trachlight lightwand
Number of subjects: 300

Group type: COMPARATOR
Intervention: Bonfils fibrescope
Number of subjects: 300
Study: 20668047

Group type: EXPERIMENTAL
Intervention: rhGH (mean maximum daily dose, 1.4 ± 0.12 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 21
Study: 17202435

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFA-supplemented 20% lipid emulsion (Lipoplus)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard 20% fat emulsion (Lipofundin MCT/LCT)
Number of subjects: 40
Study: 16327500

Group type: EXPERIMENTAL
Intervention: Ultrasonic dissection (UC)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard electrosurgery (ES)
Number of subjects: 146
Study: 11931780

Group type: EXPERIMENTAL
Intervention: Immediate treatment with fomivirsen (165 microg administered intravitreously, injected weekly for three doses as induction therapy, followed by every other week as maintenance therapy)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Deferral of treatment until CMV retinitis lesions progressed
Number of subjects: 28
Study: 9803696

Group type: EXPERIMENTAL
Intervention: SBT + SW with monetary incentives (I) for completing SW
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: SBT + SW with personal trainers (PT)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: SBT + SW + PT + I
Number of subjects: 193

Group type: COMPARATOR
Intervention: SBT
Number of subjects: 193
Study: 7701451

Group type: EXPERIMENTAL
Intervention: Fenoterol 5 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2651367

Group type: EXPERIMENTAL
Intervention: Intravenous gamma-globulin (0.5 g/kg/wk)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (17 infants with birthweight ≤ 1500 g and 20 infants with birthweight 1501-2000 g)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Infants under intensive care receiving intravenous gamma-globulin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Infants with sepsis
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Post-dose serum IgG levels
Number of subjects: 80
Study: 31454351

Group type: EXPERIMENTAL
Intervention: Standard RUTF dose throughout treatment
Number of subjects: 801

Group type: COMPARATOR
Intervention: Reduced RUTF dose after two weeks
Number of subjects: 801

Group type: COMPARATOR
Intervention: Reduced RUTF dose after two weeks (children under 12 months)
Number of subjects: 801
Study: 29092882

Group type: EXPERIMENTAL
Intervention: Cowpea
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Common bean
Number of subjects: 355

Group type: COMPARATOR
Intervention: Control
Number of subjects: 355
Study: 25672923

Group type: EXPERIMENTAL
Intervention: Intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mitoxantrone (MTX) 20 mg every month for 6 months
Number of subjects: 21
Study: 24392700

Group type: EXPERIMENTAL
Intervention: Experiential/ruminative self‐focus conditions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rumination and health anxiety
Number of subjects: 60
Study: 23030430

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM)
Number of subjects: 212
Study: 19812448

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 2594

Group type: COMPARATOR
Intervention: HIV treatment without concomitant statin use (Control)
Number of subjects: 2594
Study: 17483155

Group type: EXPERIMENTAL
Intervention: Fenofibrate (160 mg/day)
Number of subjects: 59
Study: 15231551

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 191

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 191
Study: 11603388

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 micrograms/kg body weight)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 1% topical lindane lotion
Number of subjects: 200
Study: 9587747

Group type: EXPERIMENTAL
Intervention: Spiral CT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional CT
Number of subjects: 60
Study: 8027926

Group type: EXPERIMENTAL
Intervention: Buccoadhesive film
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buccoadhesive tablet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sublingual capsule
Number of subjects: 6
Study: 2644962

Group type: EXPERIMENTAL
Intervention: Amethocaine preparation (0.5 g applied for 30 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eutectic Mixture of Local Anaesthetics (EMLA) (2.5 g applied for 60 min under an occlusive dressing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amethocaine preparation vs EMLA
Number of subjects: 0
Study: 53598

Group type: EXPERIMENTAL
Intervention: Twice-weekly isoniazid 15 mg/kg plus rifampicin 900 mg (HR2 regimen)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Twice-weekly isoniazid 15 mg/kg plus rifampicin 600 mg (LR2 regimen)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Once-weekly isoniazid 15 mg/kg plus rifampicin 900 mg (HR1 regimen)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Once-weekly isoniazid 15 mg/kg plus rifampicin 600 mg (LR1 regimen)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Rifampicin 25 mg supplement
Number of subjects: 481
Study: 31276986

Group type: EXPERIMENTAL
Intervention: Enhanced profile with graphical representation of prescriptions and identified risky prescribing patterns
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard profile
Number of subjects: 50
Study: 28832280

Group type: EXPERIMENTAL
Intervention: Immediate vaccination with a three‐dose hepatitis B vaccine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Deferred vaccination (at 12 months)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Immediate vaccination group
Number of subjects: 150

Group type: COMPARATOR
Intervention: Deferred vaccination group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall acceptability of trial procedures and services
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Future trial participation motivation
Number of subjects: 150
Study: 26117150

Group type: EXPERIMENTAL
Intervention: Self-administered LAIV (SA)
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Healthcare worker-administered LAIV (HCWA)
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: Self-administration (SA)
Number of subjects: 1077
Study: 23612197

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate (200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21713729

Group type: EXPERIMENTAL
Intervention: Acupressure wristbands applied at the P6 points
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.2 mg/kg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg iv
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 200
Study: 18850765

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duloxetine 60 mg/day
Number of subjects: 0
Study: 16156391

Group type: EXPERIMENTAL
Intervention: Guaiac faecal blood testing
Number of subjects: 300000

Group type: COMPARATOR
Intervention: Immunochemical testing
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: Involvement of GPs based on personal skills
Number of subjects: 300000
Study: 12173201

Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (PLMA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Classic laryngeal mask airway (LMA)
Number of subjects: 80
Study: 10499406

Group type: EXPERIMENTAL
Intervention: Nondistinctive image
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cleft lip image
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Misshapen nose image
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 100
Study: 8522638

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg orally once daily for 6 days
Number of subjects: 12
Study: 2185026

Group type: EXPERIMENTAL
Intervention: Surfactant (100 mg phospholipid/kg, 4 ml/kg)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Air (4 ml/kg)
Number of subjects: 106
Study: 349091

Group type: EXPERIMENTAL
Intervention: Cefamandole (500 mg every 8 hr for 7 days)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Cefazolin (500 mg every 8 hr for 7 days)
Number of subjects: 65
Study: 29555485

Group type: EXPERIMENTAL
Intervention: Chronobiological treatment (light therapy) for Delayed Sleep-Wake Phase Disorder for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Good sleeping adolescents (control group)
Number of subjects: 0
Study: 27230855

Group type: EXPERIMENTAL
Intervention: 1 mg/d rasagiline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25230559

Group type: EXPERIMENTAL
Intervention: Beta-carotene (10 mg per day for 12 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Reference group (no antioxidants, drugs, vitamins or dietary supplements)
Number of subjects: 82
Study: 23773316

Group type: EXPERIMENTAL
Intervention: DASH diet recommendations for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual dietary advice (UDA) for 6 weeks
Number of subjects: 60
Study: 19394598

Group type: EXPERIMENTAL
Intervention: Doxycycline 20 mg orally twice a day after LNG-SI insertion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo orally twice a day after LNG-SI insertion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Doxycycline 20 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19007597

Group type: EXPERIMENTAL
Intervention: Impella LP2.5
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 26
Study: 16422827

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 12868026

Group type: EXPERIMENTAL
Intervention: Entonox (50:50 N2O/O2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Air (placebo)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 100
Study: 10877482

Group type: EXPERIMENTAL
Intervention: Wearing an elastic lumbar back support
Number of subjects: 0
Study: 9437192

Group type: EXPERIMENTAL
Intervention: n-3 diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: n-6 diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: saturated diet
Number of subjects: 26
Study: 8475547

Group type: EXPERIMENTAL
Intervention: OG37-325
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 0
Study: 3515928

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31203569

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) using light-emitting diode (LED) irradiation at 150 J
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) using light-emitting diode (LED) irradiation at 300 J
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (no PBM)
Number of subjects: 11
Study: 29258362

Group type: EXPERIMENTAL
Intervention: Negative cognitive style
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Cortisol response to laboratory stress induction
Number of subjects: 179
Study: 26905354

Group type: EXPERIMENTAL
Intervention: Air-lock technique (ALT) at the dorsogluteal site (DS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Air-lock technique (ALT) at the ventrogluteal site (VS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No air-lock technique at the dorsogluteal site (DS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No air-lock technique at the ventrogluteal site (VS)
Number of subjects: 60
Study: 25348157

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study: 22873680

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg every 12 hours plus fluvoxamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo every 12 hours plus fluvoxamine
Number of subjects: 42
Study: 20033055

Group type: EXPERIMENTAL
Intervention: CD3(+)/CD19(+)-depleted PBSC grafts
Number of subjects: 0

Group type: COMPARATOR
Intervention: CD34(+)-selected PBSC grafts
Number of subjects: 0
Study: 18614889

Group type: EXPERIMENTAL
Intervention: Iloprost (group 1; 11 SSF) for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tramadol (group 2; 5 SSF) for 4 weeks
Number of subjects: 14
Study: 16018911

Group type: EXPERIMENTAL
Intervention: Reports of CAM RCTs
Number of subjects: 600

Group type: COMPARATOR
Intervention: Reports of CM RCTs
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Reports in English for CAM trials
Number of subjects: 600

Group type: COMPARATOR
Intervention: Reports in other languages for CAM trials
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Reports in English for CM trials
Number of subjects: 600

Group type: COMPARATOR
Intervention: Reports in other languages for CM trials
Number of subjects: 600
Study: 11980746

Group type: EXPERIMENTAL
Intervention: Women with small intramural fibroids undergoing IVF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (women without fibroids)
Number of subjects: 0
Study: 10392939

Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Iodinated contrast material
Number of subjects: 35
Study: 8945569

Group type: EXPERIMENTAL
Intervention: Oral immunization
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Rectal immunization
Number of subjects: 13
Study: 1627428

Group type: EXPERIMENTAL
Intervention: Radiation therapy (XRT) with full axillary dissection and gross removal of the tumor, followed by 4500 to 5000 cGy to the whole breast and a boost to the tumor bed of 1500 to 2000 cGy; patients with positive axillary dissections also received cyclophosphamide and doxorubicin
Number of subjects: 237

Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 237
Study: 6702864

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 29
Study: 30674240

Group type: EXPERIMENTAL
Intervention: Valganciclovir 450 mg daily (group 1)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Valganciclovir 900 mg daily (group 2)
Number of subjects: 196
Study: 27863065

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117